News
In this prospective cohort study, participants with social risk factors at the time of SARS-CoV-2 infection had a higher risk ...
In this randomized controlled trial, rituximab was not superior to standard treatment in inducing remission in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results